Great Lakes Advisors’s Astrana Health ASTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$832K Hold
17,932
– – 0.01% 552
2026
Q1
$440K Hold
17,932
– – ﹤0.01% 619
2025
Q4
$445K Buy
17,932
+5,563
+45% +$148K ﹤0.01% 633
2025
Q3
$351K Buy
+12,369
New +$335K ﹤0.01% 671
2025
Q2
– Sell
-7,373
Closed -$229K – 879
2025
Q1
$229K Sell
7,373
-24,728
-77% -$824K ﹤0.01% 741
2024
Q4
$1.01M Sell
32,101
-8,346
-21% -$396K 0.01% 576
2024
Q3
$2.34M Sell
40,447
-791
-2% -$38.9K 0.02% 457
2024
Q2
$1.67M Buy
+41,238
New +$1.64M 0.01% 489

Other funds holding ASTH

Great Lakes Advisors's ASTH Position: Q2 2026 in Review

Great Lakes Advisors held its Astrana Health (ASTH) position steady in Q2 2026 at 17,932 shares worth $832K. The position accounts for 0.01% of the portfolio, ranked #552.

Great Lakes Advisors first reported a position in ASTH in Q2 2024 and has held it in 8 quarters since. The position peaked at $2.34M in Q3 2024. 209 funds tracked by Wall St. Rank hold ASTH as of Q2 2026.

  • Great Lakes Advisors held 17,932 shares of Astrana Health worth $832K as of Q2 2026.
  • Great Lakes Advisors left its Astrana Health share count unchanged in Q2 2026.
  • Astrana Health made up 0.01% of Great Lakes Advisors's portfolio in Q2 2026, its #552 holding.
  • Great Lakes Advisors first reported a position in Astrana Health in Q2 2024 and has held it in 8 quarters since.
  • Great Lakes Advisors's Astrana Health position peaked at $2.34M in Q3 2024.
  • 209 funds tracked by Wall St. Rank held Astrana Health as of Q2 2026.

Based on Great Lakes Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.